Adial Pharmaceuticals, Inc. Public Float
Adial Pharmaceuticals, Inc. (ADIL) had Public Float of $6.48 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $6.48M.
- 2024-06-30: Entity Public Float $4.83M.
- 2023-06-30: Entity Public Float $5.39M.
- 2022-06-30: Entity Public Float $31.27M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.48M 10-K · filed 2026-03-05 |
| 2024-06-30 | $4.83M 10-K · filed 2025-03-04 |
| 2023-06-30 | $5.39M 10-K · filed 2024-04-01 |
| 2022-06-30 | $31.27M 10-K · filed 2023-03-30 |
| 2021-06-30 | $40.50M 10-K · filed 2022-03-28 |
| 2020-06-30 | $14.67M 10-K · filed 2021-03-22 |
| 2019-06-28 | $12.31M 10-K · filed 2020-03-20 |
| 2018-06-29 | $15.03M 10-K · filed 2019-02-19 |
| 2018-06-27 | $15.03M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |